Bai Weiya, Cui Xiaoxian, Xie Youhua, Liu Jing
Key Laboratory of Medical Molecular Virology (MOH & MOE) and Institutes of Biomedical Sciences, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Viruses. 2016 May 10;8(5):125. doi: 10.3390/v8050125.
The Hepadnaviridae family of small, enveloped DNA viruses are characterized by a strict host range and hepatocyte tropism. The prototype hepatitis B virus (HBV) is a major human pathogen and constitutes a public health problem, especially in high-incidence areas. Reporter-expressing recombinant viruses are powerful tools in both studies of basic virology and development of antiviral therapeutics. In addition, the highly restricted tropism of HBV for human hepatocytes makes it an ideal tool for hepatocyte-targeting in vivo applications such as liver-specific gene delivery. However, compact genome organization and complex replication mechanisms of hepadnaviruses have made it difficult to engineer replication-competent recombinant viruses that express biologically-relevant cargo genes. This review analyzes difficulties associated with recombinant hepadnavirus vector development, summarizes and compares the progress made in this field both historically and recently, and discusses future perspectives regarding both vector design and application.
嗜肝DNA病毒科的小型包膜DNA病毒具有严格的宿主范围和肝细胞嗜性。乙型肝炎病毒(HBV)原型是一种主要的人类病原体,构成了一个公共卫生问题,特别是在高发病率地区。表达报告基因的重组病毒是基础病毒学研究和抗病毒治疗开发的有力工具。此外,HBV对人类肝细胞的高度限制性嗜性使其成为体内应用(如肝脏特异性基因递送)中肝细胞靶向的理想工具。然而,嗜肝DNA病毒紧凑的基因组结构和复杂的复制机制使得构建能够表达生物学相关货物基因的具有复制能力的重组病毒变得困难。本文综述分析了重组嗜肝DNA病毒载体开发中存在的困难,总结并比较了该领域历史上和近期取得的进展,并讨论了载体设计和应用的未来前景。